MiNK Therapeutics, Inc. Common Stock (INKT) is a publicly traded Healthcare sector company. As of September 22, 2026, INKT trades at $12.07 with a market cap of $61.49M and a P/E ratio of -4.18. INKT moved +0.00% today. Year to date, INKT is +9.87%; over the trailing twelve months it is -18.82%. Its 52-week range spans $5.55 to $76.00. Analyst consensus is buy with an average price target of $35.00. Rallies surfaces INKT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for INKT shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $12.07 |
| Market Cap | $61.49M |
| P/E Ratio | -4.18 |
| EPS | $-2.93 |
| Dividend Yield | 0.00% |
| 52-Week High | $76.00 |
| 52-Week Low | $5.55 |
| Volume | 1.84K |
| Avg Volume | 0 |
| Revenue (TTM) | $180.25K |
| Net Income | $-12.49M |
| Gross Margin | 0.00% |
1 analysts cover INKT: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $35.00.